Across TCGA pan-cancer cohorts, NCMAP Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated NCMAP data layer compared with 24 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher NCMAP Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated NCMAP expression acts as an unfavorable survival marker.

UCEC and CESC are the cancer types where NCMAP Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	II,III,IV	0.231	0.768	.010	24	view →
CESC	OS	Median	All	0.227	0.798	.002	18	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: NCMAP tumor-vs-normal RNA expression · all NCMAP data types